
### [NCIT:C4340](http://purl.obolibrary.org/obo/NCIT_C4340)
**Label:** Peripheral T-Cell Lymphoma, Not Otherwise Specified

**Subclasses:** [NCIT:C7205](http://purl.obolibrary.org/obo/NCIT_C7205) (Lymphoepithelioid Variant Peripheral T-Cell Lymphoma), [NCIT:C7204](http://purl.obolibrary.org/obo/NCIT_C7204) (T-Zone Variant Peripheral T-Cell Lymphoma), [NCIT:C80375](http://purl.obolibrary.org/obo/NCIT_C80375) (Follicular T-Cell Lymphoma), [NCIT:C9339](http://purl.obolibrary.org/obo/NCIT_C9339) (Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified), 

**Class expressions from DL-Learner:**

- [NCIT:C39657](http://purl.obolibrary.org/obo/NCIT_C39657) (Neoplastic T-Lymphocyte with Clear Cytoplasm) 55.00%
- [NCIT:C39600](http://purl.obolibrary.org/obo/NCIT_C39600) (Neoplastic Medium-Sized T-Lymphocyte) 55.00%
- Thing 53.22%
- [NCIT:C38641](http://purl.obolibrary.org/obo/NCIT_C38641) (Neoplastic T-Lymphocyte) 40.41%
- [NCIT:C39605](http://purl.obolibrary.org/obo/NCIT_C39605) (Neoplastic Small T-Lymphocyte) 40.36%
- [NCIT:C39605](http://purl.obolibrary.org/obo/NCIT_C39605) (Neoplastic Small T-Lymphocyte) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 40.36%
- [NCIT:C39605](http://purl.obolibrary.org/obo/NCIT_C39605) (Neoplastic Small T-Lymphocyte) and (not ([NCIT:C39004](http://purl.obolibrary.org/obo/NCIT_C39004) (B-Cell Survival Pathway))) 40.36%
- [NCIT:C39605](http://purl.obolibrary.org/obo/NCIT_C39605) (Neoplastic Small T-Lymphocyte) and (not ([NCIT:C38999](http://purl.obolibrary.org/obo/NCIT_C38999) (BARD1 Pathway))) 40.36%
- [NCIT:C39605](http://purl.obolibrary.org/obo/NCIT_C39605) (Neoplastic Small T-Lymphocyte) and (not ([NCIT:C38998](http://purl.obolibrary.org/obo/NCIT_C38998) (BAD Regulation Pathway))) 40.36%
- [NCIT:C39605](http://purl.obolibrary.org/obo/NCIT_C39605) (Neoplastic Small T-Lymphocyte) and (not ([NCIT:C38997](http://purl.obolibrary.org/obo/NCIT_C38997) (Cancer Susceptibility Pathway))) 40.36%
- [NCIT:C39605](http://purl.obolibrary.org/obo/NCIT_C39605) (Neoplastic Small T-Lymphocyte) and (not ([NCIT:C38996](http://purl.obolibrary.org/obo/NCIT_C38996) (ATM Signaling Pathway))) 40.36%
- [NCIT:C39605](http://purl.obolibrary.org/obo/NCIT_C39605) (Neoplastic Small T-Lymphocyte) and (not ([NCIT:C38995](http://purl.obolibrary.org/obo/NCIT_C38995) (Angiotensin II Signaling Pathway))) 40.36%
- [NCIT:C39605](http://purl.obolibrary.org/obo/NCIT_C39605) (Neoplastic Small T-Lymphocyte) and (not ([NCIT:C38992](http://purl.obolibrary.org/obo/NCIT_C38992) (Ribosomal Biogenesis Pathway))) 40.36%
- [NCIT:C39605](http://purl.obolibrary.org/obo/NCIT_C39605) (Neoplastic Small T-Lymphocyte) and (not ([NCIT:C38981](http://purl.obolibrary.org/obo/NCIT_C38981) (AKT Signaling Pathway))) 40.36%
- [NCIT:C39605](http://purl.obolibrary.org/obo/NCIT_C39605) (Neoplastic Small T-Lymphocyte) and (not ([NCIT:C38975](http://purl.obolibrary.org/obo/NCIT_C38975) (Agrin Pathway))) 40.36%


